Background-The hypothesis that the failing heart may be energy-starved is supported in part by observations of reduced rates of adenosine 5Ј-triphosphate (ATP) synthesis through the creatine kinase (CK) reaction, the primary myocardial energy reservoir, in patients with heart failure (HF). Although murine models have been used to probe HF pathophysiology, it has not been possible to noninvasively measure the rate of ATP synthesis through CK in the in vivo mouse heart. The purpose of this work was to exploit noninvasive spatially localized magnetic resonance spectroscopy techniques to measure ATP flux through CK in in vivo mouse hearts and determine the extent of any reductions in murine HF. Methods and Results-The Triple Repetition Time Saturation Transfer (TRiST) magnetic resonance spectroscopy method of measuring ATP kinetics was first validated in skeletal muscle, rendering similar results to conventional saturation transfer magnetic resonance spectroscopy. In normal mouse hearts, the in vivo CK pseudo-first-order-rate constant, k F , was 0.32Ϯ0.03 s Ϫ1 (meanϮSD) and the rate of ATP synthesis through CK was 3.16Ϯ0.47 mol/g/s. Thoracic aortic constriction reduced k F by 31% (0.23Ϯ0.03 s
A denosine 5Ј-triphosphate (ATP) is the source of chemical energy that maintains intracellular homeostasis and fuels myocardial function. Relatively large rates of ATP synthesis are required to maintain normal cardiac contractile function, and it has been hypothesized that inadequate ATP supply contributes to the contractile dysfunction in heart failure (HF). 1 The observations that pharmacological HF agents that reduce metabolic demand improve outcomes whereas those that increase energetic demands worsen them are consistent with the energy-starvation hypothesis. [1] [2] 
Editorial see p 2 Clinical Perspective on p 50
Mouse models offer novel and appealing means to investigate the mechanistic link between altered energy metabolism and contractile function because they allow genetargeted interventions not currently possible in larger mammalian species and humans. In several important ways, murine models mimic functional and energetic aspects of normal human cardiac physiology. 3 Among many murine HF models, thoracic aortic constriction (TAC) is one that results in pressure-overload hypertrophy, progresses to HF, and shares some gross energetic and functional similarities with clinical human HF. 4 One factor that has limited testing of the energy-starvation hypothesis is the inability to noninvasively quantify energy transfer and, in particular, the rate of ATP synthesis in the in vivo beating heart. From mice to humans, 31 P magnetic resonance spectroscopy (MRS) is the only noninvasive, nondestructive means to quantify the concentrations of cardiac high-energy phosphates, ATP, and creatine phosphate (PCr), which are rapidly and reversibly converted by the creatine kinase (CK) reaction, the primary energy reserve of the heart. 31 P MRS approaches have identified moderate reductions in cardiac PCr/ATP ratio and minimally reduced [ATP] in patients with HF. [5] [6] [7] 31 P MRS techniques called saturation transfer (ST) use frequency-selective irradiation pulses and enable measurement of the rate of ATP synthesis through CK in the beating heart. Because conventional ST approaches are extremely time-consuming, more rapid ST approaches have been described recently 8 that have enabled, for the first time, measurement of the rate of ATP synthesis through CK in the human heart and detection of 50% to 70% reductions in the rate of ATP synthesis through CK in HF. 8 -10 The extremely small size (Ϸ0.1 g) and rapid rate (Ϸ600/ min) of the mouse heart complicate metabolic measurements, including those with 31 P MRS. Most mouse 31 P MRS studies have been conducted in isolated, perfused hearts. [11] [12] [13] [14] Noninvasive, spatially localized in vivo 31 P MRS studies can be performed under physiological conditions [3] [4] and permit repeated studies in the same animals as pathology evolves. 4 Such approaches have largely been limited to measures of cardiac PCr/ATP ratio, although more recently in vivo measures of the absolute concentrations of murine cardiac [ATP] and [PCr] were described and validated. 15 Unlike the human heart, there have been no reported measures of the rate of ATP synthesis through CK in the in vivo mouse heart. The measurements of ATP flux in the mouse heart have been inaccessible because of long times required by conventional ST techniques. In the present study, we apply the Triple Repetition Time Saturation Transfer (TRiST) method for rapidly measuring ATP flux through CK in the human heart 10 to measure CK reaction kinetics in the in vivo mouse heart. There were 2 aims for this study. First, we sought to adapt and validate the 31 P MR TRiST method for measuring muscle CK reaction kinetics in the in vivo mouse. Once validated, we applied the new 31 P MRS saturation transfer approach to test the hypothesis that in vivo myocardial CK reaction kinetics are reduced in the TAC model of murine HF.
Methods
The procedure and protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Johns Hopkins University. Experiments were carried out on a Bruker Biospec magnetic resonance imaging (MRI)/MRS spectrometer equipped with a 4.7-T/40-cm Oxford magnet and a 12-cm actively shielded gradient set, using a custom built probe assembly as previously described. [3] [4] 15 
Skeletal Muscle Studies
Before proceeding to experiments on the heart, the TRiST method was validated in a series of nonlocalized (NL) saturation transfer studies on mouse upper thigh muscle (nϭ5), where both TRiST and conventional saturation transfer measures could be obtained in the same examination within a reasonable amount of total experimental time. The details of these experiments are as follows: conventional NL ST measurements were performed using a set of 9 TR values of 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 10.0, and 16.0 seconds, with 128 signal averages (NEX) and 2 dummy scan (DS), except for the 2 longest TR values, where NEXϭ64 and DSϭ2 were used to keep the experimental time within reasonable limits. Signal amplitudes for these 2 experiments with NEXϭ64 were multiplied by 2 to correct for the reduced number of averages. In addition, 2 more spectra were obtained with TRϭ16 seconds, one with saturating pulse placed equidistant from the PCr signal, but downfield, and the other with no saturation pulse at all. The intensities of the PCr signal were then used to calculate T 1 Ј, using the conventional progressive saturation method, as previously explained. 10 For the TRiST method, the T 1 Ј was determined with the 2TR method using signal intensity values acquired with TRϭ1.5 and 16 seconds from the same data set. The pseudo-first-order rate constant k F was determined using the following equation as explained in Reference 10.
ͬ

Heart Studies
In vivo MRI/MRS studies were carried out on 11 male control mice (weight, 34Ϯ5 g) and 10 others 7 to 8 weeks after TAC (weight, 36Ϯ6 g), as previously described. 4, 15 TAC was performed as previously described. 16 Anesthesia was induced with Ϸ2% isoflurane in an induction chamber and maintained at Ϸ1% in 50/50 air/O 2 mixture delivered through a nose cone, as previously described. [3] [4] 15 The probe set included a 31 P MR spectra were obtained with a 1-dimensional chemical shift imaging sequence (16-mm field of view, 16 phaseencoding steps) using modified BIR4 90°adiabatic pulses. Two acquisitions with different untriggered repetition periods (TRϭ1.5 seconds, NEXϭ96, TRϭ6 seconds, and NEXϭ32) were acquired in the presence of saturating irradiation pulse applied to the exchanging CK moiety: ␥-phosphate of ATP at Ϫ2.5 ppm, relative to PCr, and another acquisition, fully relaxed (TRϭ10 seconds, NEXϭ16) in the presence of control irradiation applied at ϩ2.5 ppm. The measured signal intensities were normalized for different NEX. To measure PCr concentration from the acquisition with control saturation, separate studies were performed (nϭ4) in which 2 cardiac spectra were obtained with 1-dimensional chemical shift imaging and TRϭ16 seconds, one with the saturating pulse placed at ϩ2.5 ppm and the other with no saturation pulse at all. Intensities of the PCr signal from these 2 cardiac spectra were used to determine the average correction factor (1.1) arising from spillover effects of the radiofrequency pulse to measure PCr concentration.
After the mouse examinations were completed, external phantom experiments were also performed on the same day with the same coil set under comparable conditions to calculate the absolute concentrations of PCr and ATP, as described previously. 15 1 H MRIs were analyzed with commercial Paravision software and 31 P MR spectral peak areas determined with in-house custom software. 17 Metabolite signal intensities were determined from the integrated peak areas of the PCr and ATP resonances from voxels centered on cardiac muscle as identified from the high-resolution 1 H MRIs, as described previously. [3] [4] Voxel shifting was performed when necessary to optimize slice alignment with cardiac structures and minimize skeletal muscle contamination of cardiac spectra. 18 Although both heart and chest are curved and the voxels extend in both directions, the surface coil size and profile limit signal contributions from the lateral dimensions, and thus more than 93% of signal in cardiac voxels obtained with this approach are from the mouse heart. 3 The same slice was selected to measure the inorganic phosphate peak area in the external phosphate phantom. The [PCr], [ATP] , and PCr/ATP ratio were determined for control and TAC mouse hearts as previously explained. 15 T 1 Ј was calculated from the area of the PCr signal with TR short (1.5 seconds) and TR long (6 seconds) according to the 2TR method. 19 The k f (s Ϫ1 ) was determined for control and TAC mouse hearts using the TRiST method 10 and the rate of ATP synthesis through CK (mol/g per s) calculated as the product of k f and [PCr], as previously described. 8, 9 To evaluate the degree of hypertrophy and extent of contractile dysfunction induced by TAC in this setting, a separate cine MRI study was performed in some animals using the following protocol. Specifically, left ventricular (LV) function was quantified from multislice FLASH cine MRIs (15 frames, TEϭ1.5 ms, TRϭ7 ms, flip angleϭ45°) by using ECG and respiratory gating, as previous reported. 4 MRIs were analyzed with ImageJ software, and end-diastolic volume (EDV), end-systolic volume (ESV), LV mass, and LV ejection fraction (EF) were calculated as previously described. 3, 4 
CK Activity
After the MRS study was complete, mice were euthanized and the hearts were excised and immediately frozen in liquid nitrogen. Ventricular tissue was homogenized in ice-cold potassium phosphate buffer containing 1 mmol/L EDTA and 1 mmol/L ␤-mercaptoethanol, pH 7.4 (final concentration, 5 mg tissue/mL). An aliquot was removed for protein assay by the method of Lowry et al, 20 using bovine serum albumin as the standard. Subsequently, Triton X-100 was added to the homogenate at a final concentration of 0.1% and total CK activity was measured spectrophotometrically (Molecular Devices Sunnyvale, Calif) (340 nm, 37°C) 21 using a kit (C184 -0A) from Catachem and according to the manufacturer's instructions. CK activity was expressed as IU/mg protein. Lung and body weights were determined at the time of death to assess for pulmonary congestion.
Statistics
A paired t test was performed to compare conventional and TRiST measures of T 1 Ј and k f in the same animals. The PCr/ATP ratio, [PCr], [ATP], T 1 Ј, k f ,, and CK reaction kinetics of normal and TAC mice heart were compared using the nonpaired Student t test. Differences were considered statistically significant at PՅ0.05. All results are shown as meanϮSD.
Results
Skeletal Muscle
Because a conventional saturation transfer experiment with spatial localization could not be conducted in the in vivo mouse heart in a time frame that would be tolerated by an anesthetized animal, we validated the faster TRiST approach in the in vivo mouse with NL studies comparing conventional nine point progressive saturation (PS) measurements with those from TRiST in skeletal muscle. A representative high-resolution transverse 1 H MR thigh image and corresponding NL skeletal muscle 31 P MR spectra under different saturating conditions are shown in Figure 1 . Figure 2 shows a graph of the PCr peak area versus repetition time of the 9 acquisitions and the resulting monoexponential T 1 Ј fit from one set of in vivo data for the skeletal muscle. The mean in vivo T 1 Ј in the presence of saturating irradiation on ␥-phosphate of ATP for conventional PS and TRiST methods were 1.94Ϯ0.03 seconds and 1.95Ϯ0.04 seconds, respectively ( Figure 3 , nϭ5, mean difference Ϸ0.5%, Pϭ0.64 by paired comparison). The 9-point PS data acquisition took 31 P spectra acquired with ␥-phosphate of ATP saturation at different TR (TR values listed to left of each spectrum); B, PCr signal intensity (a.u.) versus TR (s) during saturation of ␥-phosphate of ATP in the skeletal muscle of same representative mouse. T 1 Ј was determined both by conventional saturation transfer analysis, fitting all 9 data points (light thin line), and by the 2TR method, using only the data points acquired at TR of 1.5 seconds and 16 seconds (dark, thick, dotted line).
Ϸ78 minutes as compared with Ϸ22 minutes for TRiST, a time saving of Ϸ73% for the same measurement. Figure 3 shows that in these NL measurements, the TRiST method renders the same mean in vivo k f as does the conventional PS approach (0.26Ϯ0.01 s Ϫ1 and 0.26Ϯ0.01 s Ϫ1 , Pϭ0.56).
Cardiac Muscle
As compared with control animals (nϭ5), TAC hearts (nϭ6) exhibited a significant increase in LV mass (90Ϯ5 mg versus 209Ϯ27 mg, control versus TAC, respectively, PϽ0.0001) and the ratio of LV mass (mg)/body mass (g) (2.5Ϯ0. Figure 4 . A representative high-resolution transverse 1 H MR cardiac image and corresponding spatially localized cardiac 31 P MR spectra under different saturating conditions from the anterior wall of the heart are shown in Figure 5 . The decrease in the PCr resonance with selective saturation of ␥-ATP is directly proportional to the rate of ATP synthesis through the CK reaction in the heart. 22 15 In control and TAC mice, the mean in vivo T 1 Ј was 1.64Ϯ0.16 seconds and 2.21Ϯ0.27 seconds, respectively (PϽ0.0001). Mean in vivo cardiac k f was reduced by 31% in TAC (0.23Ϯ0.03 s Ϫ1 ) as compared with that of control mice (0.32Ϯ0.03 s Ϫ1 , PϽ0.0001) and these values and the relative reduction also agree with those in other species, including humans. 8 -9,23,24 The mean in vivo forward rate of ATP synthesis through cardiac CK was 3.16Ϯ0.47 mol/g/s in control mice and 1.54Ϯ0.25 mol/g/s in TAC mice (PϽ0.0001). The absolute values and the Ϸ50% reduction in the failing hearts are similar to those observed in normal and failing human studies. 8 -9 In vitro CK activity measured in the same hearts was also significantly decreased in TAC mice (6.06Ϯ1.7 IU/mg protein) as compared with that of controls (9.66Ϯ1.8 IU/mg protein, PϽ0.0006). The relationship between cardiac energetic indices derived from MRS (PCr/ATP and ATP flux through CK) and functional/anatomic indices derived from MRI (EF, ESV, mass) are shown in Figure 7 .
Discussion
There are 5 novel aspects to this work. First, these are the first noninvasive, direct measures of ATP synthesis in the in vivo mouse heart. They were acquired with a noninvasive 31 P MRS ST method, TRiST, initially developed for humans, adapted here to mice, and validated here in vivo by comparison with conventional ST measures in skeletal muscle.
Second, despite the massive difference in size and resting rate between murine and human hearts, the rate of ATP synthesis (Ϸ3 mol/g per s) through CK, the primary myocardial energy reserve, is remarkably similar per gram between these species. Third, long-standing pressure overload and HF induced by TAC results in a Ϸ30% reduction in k f and a Ϸ50% decline in the rate of ATP synthesis through CK. Fourth, the reduction in ATP flux through CK is much greater than the reduction in PCr/ATP ratio or [ATP], suggesting the previously used indices of myocardial energetics based on metabolite pool sizes underestimate the reduction in myofibrillar ATP delivery in failing hearts. Fifth, the 50% reduction in ATP flux through CK observed here in the in vivo failing TAC mouse heart is similar to the 50% reduction in patients with dilated cardiomyopathy 8 and the 65% reduction in patients with pressure-overload hypertrophy and HF, 9 suggesting that this murine model mimics important bioenergetic aspects of human HF. CK is the primary energy reserve of the heart, reversibly exchanging a high-energy phosphate group between ATP and PCr:
This reaction rapidly buffers ADP and ATP in cardiac and skeletal muscle and can be a rapid source of ATP during ischemia and burst activity in skeletal muscle. [25] [26] [27] [28] [29] The CK reaction has also been postulated to shuttle or transfer high-energy phosphates from the mitochondria, where ATP is synthesized, to the cytosol, where it is used, and back for rephosphorylation. 30, 31 This spatial buffering function is supported by the smaller size and molecular weight of PCr and creatine, which diffuse more rapidly than ATP and ADP, and by the compartmentalization of separate mitochondrial and cytosolic isoforms of CK, also critical for CK temporal ATP buffering. 25, 26, 30 There are several derangements in CK during HF that may limit ATP transfer, and these include reductions in the pool sizes of CK substrates, reduced CK activity, altered isoform distribution and, most importantly, a reduction in the rate of ATP synthesis through CK. 1,2,28,32 31 P MRS is uniquely able to noninvasively and repetitively measure the CK reactants, ATP and PCr, and to quantify the rate of ATP flux through CK in the beating heart. 33 Saturation transfer is a class of MRS techniques that allows quantification of chemical exchange through specific reactions and such techniques were first used to explore cardiac CK kinetics nearly 30 years ago. 33 Conventional magnetization transfer experiments are very time-consuming, typically requiring 7 or more fully relaxed acquisitions for a single measurement. In addition, spatial-localization techniques, used to obtain 31 P signals from the heart in closed-chest animals, are also time-consuming as compared with simple 1-pulse experiments used in open-chest or isolated heart studies. Thus, despite the biological appeal of measuring the rate of ATP synthesis noninvasively in the in vivo beating heart under physiological conditions or as pathology develops, spatially localized conventional saturation transfer techniques simply require too much time, in some instances many hours, to be easily tolerated by anesthetized animals or by patients. The first measures of ATP flux through CK in the human heart were obtained with a new, more rapid saturation transfer approach that required fewer acquisitions under incompletely relaxed conditions by exploiting acquisitions with precise but different flip angles (4-angle saturation transfer, FAST). 22 The FAST method required approximately one-seventh the time of conventional saturation transfer and yielded a mean rate of 3.4 mol/g per s for ATP synthesis through CK in the normal human heart. 8 To overcome power limitations at higher, 3-T field strengths for patient studies, another rapid approach was developed that varied the repetition time rather than the flip angle and this method, called TRiST for triple repetition time saturation transfer, gave similar results for CK kinetics in the human heart as prior FAST reports 22 and offered a 73% time savings over conventional saturation transfer. 10 More recently, another rapid ST approach was described that uses a strategy of presaturation delays numerically optimized for the expected k f . 34 This method was used to study kinetics in the open-chest dog heart and offered a time savings of up to 82%. 34 All 3 approaches were validated by comparison to conventional saturation transfer measurements obtained under NL conditions. A similar approach for validation was used here in the in vivo closed-chest mouse.
The mouse is a commonly used, important model for many human diseases because it allows specific gene-targeted interventions of overexpression or knockout. In the absence of genetic manipulation, the normal mouse heart exhibits some fundamental similarities to normal human heart in high-energy phosphate metabolism and global LVEF. 3, 15 We adapted TRiST to the mouse heart and validated it by direct comparison with conventional ST measures in skeletal muscle. There was no significant difference between the measured T 1 Ј or k f between the 2 methods (Figures 1 and 3) , although TRiST measures took 73% less time. This time saving allowed us to perform image-guided, spatially localized TRiST measurements in the mouse heart under in vivo closed-chest conditions despite the small heart weight and rapid heart rates. Although there are large species differences in size and heart rate between mice and humans, the constancy of the cardiac PCr/ATP ratio, 3 the absolute concentrations of [PCr] and [ATP], 15 myocardial oxygen consumption, 11, 35 and, as shown in this study for the first time, the rate of ATP synthesis through CK, is striking and speaks to the central importance of the ATP reserve offered by CK across species.
The current findings of a significant Ϸ50% decrease in regeneration of myocardial ATP, through CK, in the murine TAC heart (Figure 6 ) are consistent with the prior reports in larger animal models of HF and clinical studies. In hypertrophied canine hearts 1 year after aortic banding, the in vivo rate of ATP synthesis through CK was reduced by 50%, whereas in vitro CK activity was unchanged. 36 Two months of aortic banding in Yorkshire pigs resulted in severe hypertrophy in all animals and HF in half. 37 Hypertrophied swine exhibited a 35% mean reduction in ATP flux through CK, whereas animals in HF showed a 57% reduction in ATP flux through in vivo CK and a 48% reduction in in vitro CK activity. 37 Thus, the current findings of a 50% mean reduction in ATP flux through in vivo CK in TAC mouse hearts are consistent with reductions observed in aortic-banded pigs and dogs. Changes in in vitro measures of total CK activity sometimes 37 as in this report, but not always, 36 are similar to changes in the in vivo rate of ATP synthesis through CK. Importantly, the magnitude of the reduction in ATP kinetics observed here in TAC mice is similar to that observed in failing human hearts. 8, 9 In patients with nonischemic dilated cardiomyopathy, the mean rate of ATP synthesis through CK was reduced by 50%. 8 In patients with pressure-overload hypertrophy, the rate of ATP synthesis through CK was reduced by 30% in those without HF and by 65% in those with HF symptoms. 9 Thus, a significant reduction in the rate of ATP delivery by CK is a common finding in hypertrophied and failing hearts from mice through humans. Because the magnitude of the reduction of in vivo CK ATP capacity is similar in TAC mice and failing human hearts, this model and the noninvasive repetitive aspects of the new technique appear to be appealing, important tools to probe energetic hypotheses of HF development and progression.
ATP generated by the CK reaction and that from the ATPase, the latter derived mostly from oxidative metabolism, support contractile energy demands and may be limiting under some conditions, especially high work loads in large animals. 38 Murine myocardial energy demands (per gram tissue/unit time) probably are similar to, or only modestly higher, than those of human hearts 11, 35 because the ATP requirements of the 7-to 9-fold higher murine heart rates are mostly offset by the 6-to 7-fold lower wall tension in the dramatically smaller murine LV. Because the rate of ATP synthesis through CK is similar in mice and humans, the ATP reserve provided by CK could, in theory, be inadequate at high work loads and/or in species with higher energy demands. Because the high-energy phosphate pools are small compared with their high rate of turnover 8, 9, 12 and because high-energy phosphates are consumed on a millisecond time scale during muscle contraction, 33 ,39 -41 a 50% reduction in the CK energy reservoir in the failing heart represents a significant deficit in temporal, and possibly spatial, ATP delivery. 8, 9 However, it is still not known whether in fact a reduction in the rate of ATP delivery by CK of the magnitude measured here, or a reduction in that provided by the ATPase, not studied here, is the cause of LV dysfunction in HF. Additional studies determining the direct contractile consequences of independent manipulations of the rate of ATP delivery through such reactions would be needed to answer that question as well as studies at maximal work load conditions.
There are several limitations that merit mention. First, because significant reductions in k f were previously observed in failing hearts but not in compensated, hypertrophied hearts in both pigs 37 and patients, 9 additional, serial studies are needed in mice at earlier times after TAC to determine whether k f can distinguish compensated and failing hypertrophied mouse hearts and predict the development of anatomic remodeling and decreased contractile function in this setting. Second, like other in vivo saturation transfer techniques, this 31 P MRS TRiST approach, applied to the in vivo mouse heart, cannot render CK results for the different subcellular compartments. 42 It does, however, reveal the net rate of ATP synthesis through CK, 22 and this parameter is significantly altered in HF patients. 8, 9 In summary, the first noninvasive, direct, validated measures of ATP synthesis in the in vivo mouse heart are reported. Despite the manifold difference in size and resting rate between mouse and human hearts, the rate of ATP synthesis through CK is remarkably similar per gram between these species. The rate of ATP synthesis through CK is reduced by 50% in the murine TAC heart, and this reduction is comparable to that previously reported in canine and ovine pressure-overload models and importantly in human HF. The ability to noninvasively measure ATP kinetics in the intact, in vivo mouse heart promises new insights into the role of bioenergetics in contractile dysfunction and ventricular remodeling in this animal model with readily available genetic manipulations and similarities to human physiology and clinical HF. 
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CLINICAL PERSPECTIVE
Energy metabolism fuels ongoing myocardial contraction, and altered metabolism may contribute mechanistically to several cardiac diseases including heart failure. 31 P magnetic resonance spectroscopy is the only means to noninvasively quantify the levels of myocardial high-energy phosphates, adenosine 5Ј-triphosphate (ATP) and creatine phosphate. Magnetization transfer 31 P magnetic resonance spectroscopy methods were adapted in recent years to measure the rate of ATP turnover in the human heart. Such 31 P magnetic resonance spectroscopy techniques, when combined with magnetic resonance imaging approaches, offer a powerful means to assess cardiac energy metabolism, structure, mass, and contractile function in the same examination. Murine models are increasingly used to probe molecular mechanisms of human disease because of the possibility of creating specific transgenic lines. However, the small size (ϳ0.1 g) and high rate (ϳ600/min) of the mouse heart present significant challenges for noninvasive imaging approaches. In this report, the first noninvasive in vivo measures of the rate of ATP synthesis through creatine kinase, the major myocardial energy reserve, in the murine heart are reported. They demonstrate that ATP turnover rates in normal and failing mouse hearts are comparable to those reported in human hearts. This validated, noninvasive approach to measuring ATP synthesis rates through creatine kinase in the intact mouse can be combined with anatomic and functional measures in the same examination and be repeated over time as pathology develops. The observations demonstrate that murine models recapitulate several fundamental aspects of human myocardial energy metabolism in vivo and support their use to probe specific metabolic contributions to the development and progression of heart failure.
